BEAM Delta Exposure (DEX)

Net delta exposure for Beam Therapeutics Inc (BEAM) options was $19.4M per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $9.39M.

Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Delta Exposure by Strike

Showing results for BEAM, 2026-11-20(m), calls & puts

       

Delta Exposure Stats

Showing results for BEAM, 2026-11-20(m), calls & puts



Net Delta Exposure by Expiration

Showing results for BEAM, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net DEX Call DEX Put DEX Call Wall Put Wall

BEAM Delta Exposure FAQ

What is delta exposure (DEX)?

Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.

Is BEAM delta exposure positive or negative?

Beam Therapeutics net delta exposure was positive on Nov 4, 2026, at $19.4M. It has been positive on 20 of the last 20 trading days.

How has BEAM delta exposure changed recently?

Beam Therapeutics net delta exposure went from $9.39M on Oct 7, 2026 to $19.4M on Nov 4, 2026. See the BEAM delta exposure history for a longer view.

What is Beam Therapeutics Inc?

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases.

Give feedback on this chart